PROTOCOL · CARDIOVASCULAR · sk-cardiovascular:blood-pressure

Blood Pressure Supplements That Work: 5 Evidence-Based Stack Items (and 4 to Cut)

Curated · cited · brand-agnostic · funded by the links you use Last reviewed ·
Plain version, one line: five supplements that nudge blood pressure down for real, four that waste your money, and the doses and brands we'd actually buy.Stack-kit editorial

Now the longer version. If you're managing blood pressure as a long-term concern, you've probably noticed the supplement aisle sells confidence by the bottle and evidence by the thimble. This protocol is the inverse. Five items here earned their place with cited mechanisms, named doses, specific brands, and study effect sizes. Four others get cut — including one that was the default recommendation for two solid decades before the data caught up with it.

Read this part twice if you read nothing else: this stack is a complement to prescribed antihypertensive therapy, not a replacement. Several items interact in real, measurable ways with ACE inhibitors, ARBs, diuretics, and beta blockers — the blood-pressure drugs your prescriber likely already has you on. Every one of those interactions is named inline, where it belongs, not buried in a footnote. Run the stack past your prescriber before you start. We don't say that as legal cover. We say it because the prescriber check is a step in the protocol, same as the dose.


Quick answer

The stack — 5 items, ~$95–135/month if you buy all 5:

  1. Magnesium glycinate — 300–400 mg elemental / day, evening. Pure Encapsulations. Systolic −2.0 mmHg.
  2. Dietary nitrate (beetroot) — 6.4 mmol / day, morning. Beet It Sport. Systolic −7.7 mmHg in hypertensives.
  3. Potassium chloride — 1,000–1,500 mg / day via salt substitute. NoSalt or LoSalt. Systolic −6.8 mmHg at therapeutic intake.
  4. CoQ10 (ubiquinol) — 100–200 mg / day with fat. Pure Encapsulations Ubiquinol-QH. Modest effect; strongest case if you're on a statin.
  5. EPA/DHA omega-3 — 2,000–3,000 mg combined / day with fat. Nordic Naturals ProOmega 2000. Systolic −4.5 mmHg at ≥2 g/day.

Cut these: L-arginine monotherapy, "heart health" multi-blends, high-dose calcium supplementation, sodium-loading endurance electrolytes.

Key caveat: if you're on an ACE inhibitor, ARB, or potassium-sparing diuretic, potassium supplementation carries real hyperkalemia risk (too much potassium in the blood, which can affect the heart's rhythm). Ask your prescriber to check a basic metabolic panel before starting and again at 4–6 weeks.


The protocol — detailed

1. Magnesium glycinate (daily, foundational)

Magnesium glycinate

IN
Brand
Pure Encapsulations Magnesium Glycinate — 120 mg elemental per capsule, no fillers, third-party-tested, USP-verified manufacturing. ~$22 / 90 capsules. Thorne Magnesium Bisglycinate is the comparable second pick.
Dose
300–400 mg elemental magnesium per day, taken with the evening meal. Glycinate form has the best absorption-to-GI-tolerance ratio. Citrate works but loosens stools at therapeutic doses. Oxide is mostly unabsorbed — skip it. Split into two doses if you experience any loose stool.
Peel back the label

Mechanism

Magnesium is a cofactor for vascular smooth muscle relaxation. Low intracellular magnesium correlates with elevated vascular tone; supplementation in deficient or sub-optimal adults produces a small, durable reduction in both systolic and diastolic pressure. The mechanism is established — vasodilation via competitive antagonism at calcium channels and direct nitric oxide modulation. The effect size is modest: real, not dramatic.

Evidence

Zhang et al. 2016 (*Hypertension*, 68:324–333), meta-analysis of 34 RCTs, N=2,028. Median dose 368 mg/day for median 3 months produced systolic reduction of 2.00 mmHg (95% CI 0.43–3.58) and diastolic reduction of 1.78 mmHg (95% CI 0.73–2.82). Effect size larger in hypertensive subgroups and in deficient subjects. Filippini et al. 2021 (*J Am Coll Nutr*) replicates the dose-response shape.

Skip when

If you have reduced renal function (eGFR <30) or are on a potassium-sparing diuretic (spironolactone, eplerenone) — magnesium accumulation risk. Also skip if your serum magnesium is already in the upper-normal range and your BP is well-controlled by existing therapy.

supports Stack-kit

Start here because it's the cheapest, the gentlest, and the one most people are quietly short on. The catch is the form on the label — get that wrong and you've bought a laxative.

Mechanism

Magnesium is a cofactor for vascular smooth muscle relaxation — in plain terms, it helps the muscle wrapping your blood vessels loosen rather than clench. When intracellular magnesium runs low, vascular tone tends to run high. Topping it up in adults who are deficient or merely sub-optimal produces a small but durable drop in both systolic and diastolic pressure: partly by competing with calcium at the channels that drive constriction, partly by nudging nitric oxide signaling. Modest is the honest word here. Real, but not dramatic — anyone promising dramatic from magnesium is selling something.

Dose and timing

300–400 mg elemental magnesium per day, with the evening meal. Glycinate wins on the absorption-to-GI-tolerance ratio, which is the whole game with magnesium. Citrate works too but loosens stools at therapeutic doses; oxide is mostly unabsorbed, so skip it outright. If you do hit loose stool, split the dose in two.

Brand we'd buy

Pure Encapsulations Magnesium Glycinate — 120 mg elemental per capsule, no fillers, third-party-tested, USP-verified manufacturing, about $22 for 90 capsules. The reason we reach for it: dose-per-capsule honesty and a clean label, not the marketing. Thorne Magnesium Bisglycinate is the comparable second pick if Pure Encapsulations is out of stock.

Study

Zhang et al. 2016 (Hypertension, 68:324–333) pooled 34 RCTs, N=2,028. A median dose of 368 mg/day over a median three months produced a systolic reduction of 2.00 mmHg (95% CI 0.43–3.58) and a diastolic reduction of 1.78 mmHg (95% CI 0.73–2.82). The effect ran larger in the hypertensive subgroups and in subjects who started out deficient — which is exactly the dose-response shape Filippini et al. 2021 (J Am Coll Nutr) went on to replicate.

Skip conditions

Reduced renal function (eGFR <30) or a potassium-sparing diuretic on board — spironolactone, eplerenone — because magnesium can accumulate. And if your serum magnesium already sits upper-normal and your BP is well-controlled, there's nothing here to chase; skip it.


2. Dietary nitrate from beetroot (daily, foundational)

Dietary nitrate

IN
Brand
Beet It Sport Nitrate 400 — concentrated 70 ml shot, standardized to 400 mg nitrate (~6.4 mmol). UK-manufactured, third-party-assayed for nitrate content (most beet supplements are NOT). ~$2.50 per shot, ~$75 per month if daily. HumanN SuperBeets is the mass-market alternative — cheaper, less…
Dose
6.4 mmol nitrate per day (one Beet It Sport shot, 70 ml). Take in the morning. Do not use antibacterial mouthwash within several hours — it eliminates the oral bacteria that perform the nitrate-to-nitrite reduction and abolishes the effect. This is the most overlooked failure mode of beetroot supplementation.
Peel back the label

Mechanism

Dietary nitrate is reduced by oral bacteria to nitrite, then to nitric oxide endogenously. Nitric oxide is the primary endothelium-derived vasodilator. Unlike L-arginine supplementation (which has been mostly disappointing in trials), dietary nitrate raises plasma nitrite reliably and produces measurable peripheral and central BP reductions within hours of ingestion. The effect compounds with consistent daily intake over weeks.

Evidence

Kapil et al. 2015 (*Hypertension*, 65:320–327), N=68 hypertensive adults, 4 weeks daily beetroot juice (250 ml). Daytime ambulatory systolic reduction of 7.7 mmHg (95% CI 3.6–11.8), diastolic 2.4 mmHg. Siervo et al. 2013 (*J Nutr*, 143:818–826) meta-analysis of 16 trials confirms ~4.4 mmHg systolic average across mixed populations. The Kapil hypertensive-population effect size is notable — among the largest reported for any single supplement intervention in this domain.

Skip when

If you are already on a nitrate-class drug (isosorbide mononitrate, nitroglycerin) — the additive vasodilation is unsafe. Also skip if you are using PDE5 inhibitors (sildenafil, tadalafil) within the same window. If you are on multiple antihypertensives and run low-end systolic readings, start at half-dose and monitor for orthostatic symptoms.

supports Stack-kit

Here's the one that surprises people: a beet shot can drop your pressure within hours. It's also the item with the single most overlooked way to ruin it, so read the timing note twice.

Mechanism

Dietary nitrate gets reduced by bacteria in your mouth into nitrite, then into nitric oxide inside the body (endogenously — meaning your own physiology makes it, you're just supplying the raw material). Nitric oxide is the body's main endothelium-derived vasodilator — the signal that tells vessels to widen. This is where L-arginine, the old standby, mostly disappointed in trials: dietary nitrate raises plasma nitrite reliably and delivers measurable peripheral and central BP reductions within hours, and the effect compounds with daily intake over weeks.

Dose and timing

6.4 mmol nitrate per day — one Beet It Sport shot, 70 ml — in the morning. Do not use antibacterial mouthwash within several hours. This is not a footnote; it's the failure mode. Mouthwash wipes out the oral bacteria doing the nitrate-to-nitrite conversion, and without them the whole effect simply doesn't happen. People who swear beetroot did nothing are very often people who rinse.

Brand we'd buy

Beet It Sport Nitrate 400 — a concentrated 70 ml shot standardized to 400 mg nitrate (~6.4 mmol), UK-manufactured, third-party-assayed for actual nitrate content. That last part is why we'd buy it: most beet supplements aren't assayed, so you're trusting a number nobody verified. About $2.50 per shot, roughly $75/month taken daily. HumanN SuperBeets is the mass-market alternative — cheaper, but the nitrate per serving is less consistent.

Study

Kapil et al. 2015 (Hypertension, 65:320–327), N=68 hypertensive adults, four weeks of daily beetroot juice (250 ml). Daytime ambulatory systolic fell 7.7 mmHg (95% CI 3.6–11.8), diastolic 2.4 mmHg. Siervo et al. 2013 (J Nutr, 143:818–826), a meta-analysis of 16 trials, lands at ~4.4 mmHg systolic averaged across mixed populations. That 7.7 figure is among the largest single-supplement effect sizes anyone has reported in this whole domain.

Skip conditions

Already on a nitrate-class drug — isosorbide mononitrate, nitroglycerin — because stacking vasodilators is unsafe. Same window as a PDE5 inhibitor (sildenafil, tadalafil): skip it. And if you're on multiple antihypertensives with low-end systolic readings, start at half-dose and watch for orthostatic symptoms (lightheadedness on standing up).


3. Potassium via salt substitute (daily, dietary-first)

Potassium

IN
Brand
NoSalt (RCN Products) or LoSalt (Klinge Foods) — both are potassium chloride, both are inexpensive (~$6–8 for several months of use). Pure-potassium-bicarbonate powders (Pure Encapsulations, NOW Foods) are available for those who dislike the metallic taste of KCl — slightly higher cost (~$18 / 250 g).
Dose
Target an additional 1,000–1,500 mg/day above your current dietary intake. US-market supplements are capped at 99 mg per capsule — useless. The practical answer is potassium chloride salt substitute (NoSalt, LoSalt, Morton Salt Substitute), ~530 mg potassium per 1/4 teaspoon, used in place of…
Peel back the label

Mechanism

Potassium counteracts sodium's effect on vascular tone and renal sodium handling. The DASH diet's BP effect is in large part a potassium effect. Most adults under-consume potassium dramatically — recommended intake is 3,500–4,700 mg/day; average US intake is ~2,600 mg. Closing that gap is the single highest-leverage dietary lever in this protocol.

Evidence

Filippini et al. 2020 (*J Am Heart Assoc*, 9:e015719), dose-response meta-analysis, 32 trials. 90 mmol/day potassium supplementation (~3,500 mg) produced systolic reduction of 6.8 mmHg in hypertensive subjects. Aburto et al. 2013 (*BMJ*, 346:f1378) WHO-commissioned meta-analysis confirms the shape — larger effects in adults with elevated baseline BP and in those with high sodium intake.

Skip when

If you are on an ACE inhibitor, ARB, potassium-sparing diuretic (spironolactone, eplerenone, amiloride, triamterene), or have reduced renal function — hyperkalemia risk is real and underappreciated. Ask your prescriber to check a basic metabolic panel before starting and again at 4–6 weeks. This is not a theoretical concern.

supports Stack-kit

This is the highest-leverage item in the protocol and also the one with the sharpest edge — the same mineral that lowers your pressure can become dangerous on the wrong medication. The fix isn't a pill. It's the salt shaker.

Mechanism

Potassium counteracts what sodium does to vascular tone and to how the kidneys handle sodium. The famous BP effect of the DASH diet is, in large part, a potassium effect wearing a fancier name. The problem is that almost nobody gets enough: recommended intake runs 3,500–4,700 mg/day, and the US average sits around 2,600 mg. Closing that gap is the single highest-leverage dietary lever in this entire protocol — bigger than any capsule below it.

Dose and timing

Aim for an additional 1,000–1,500 mg/day on top of what you already eat. Don't bother hunting for a strong capsule — US-market potassium supplements are capped at 99 mg each, which is functionally useless for this purpose. The lever that actually works is potassium chloride salt substitute: about 530 mg potassium per 1/4 teaspoon, used in place of regular table salt while cooking or at the table. Spread it across meals.

Brand we'd buy

NoSalt (RCN Products) or LoSalt (Klinge Foods) — both potassium chloride, both cheap enough to be an afterthought (~$6–8 for several months). If the slightly metallic taste of KCl bothers you, pure potassium-bicarbonate powders from Pure Encapsulations or NOW Foods do the same job for a bit more (~$18 / 250 g).

Study

Filippini et al. 2020 (J Am Heart Assoc, 9:e015719), a dose-response meta-analysis across 32 trials, found that 90 mmol/day of potassium (~3,500 mg) cut systolic pressure by 6.8 mmHg in hypertensive subjects. Aburto et al. 2013 (BMJ, 346:f1378), the WHO-commissioned meta-analysis, confirms the same shape — bigger effects in adults with elevated baseline BP and high sodium intake.

Skip conditions

This is the one to take seriously, not skim. On an ACE inhibitor, ARB, potassium-sparing diuretic (spironolactone, eplerenone, amiloride, triamterene), or with reduced renal function, the hyperkalemia risk is real and underappreciated. Ask your prescriber to check a basic metabolic panel before starting and again at 4–6 weeks. This is not theoretical.


4. CoQ10 ubiquinol form (daily, foundational)

CoQ10

IN
Brand
Pure Encapsulations Ubiquinol-QH — 100 mg per softgel, Kaneka-sourced ubiquinol (the only ubiquinol form with substantial human trial data), third-party-tested. ~$48 / 60 softgels. Qunol Ultra is the mass-market alternative — also Kaneka-sourced, cheaper per mg, slightly more filler.
Dose
100–200 mg ubiquinol per day, with a fat-containing meal. Ubiquinol (reduced form) has substantially better bioavailability than ubiquinone (oxidized form), especially in adults over 50. Take in the morning or midday; some adults report mild stimulant-adjacent alertness.
Peel back the label

Mechanism

Coenzyme Q10 is a mitochondrial electron-transport cofactor with secondary endothelial effects — it appears to improve endothelial function via reduced oxidative stress on nitric oxide signaling. The BP literature on CoQ10 is mixed but tilts positive. Effects are smaller than the headlines suggested in the 2000s but consistent across better-designed studies. It is also one of the more defensible supplement choices for adults on statin therapy, which depletes endogenous CoQ10.

Evidence

Rosenfeldt et al. 2007 (*J Hum Hypertens*, 21:297–306) meta-analysis of 12 trials reported systolic reduction of 11 mmHg / diastolic 7 mmHg — this is the headline number, and it is overstated relative to better-controlled subsequent work. Ho et al. 2016 Cochrane review (CD007435) reanalyzed and found no significant effect; methodological critiques of both sides exist. Honest framing: the floor is "modest effect at worst, meaningful at best," with the strongest case for adults on statins or with measurable mitochondrial-stress markers.

Skip when

If you are on warfarin — CoQ10 can reduce INR via vitamin-K-analog structural similarity. Also reasonable to skip if BP is already well-controlled and budget is tight; this is the item in this stack with the weakest evidence base.

supports Stack-kit

The weakest evidence in the stack — and we'll say so plainly rather than dress it up. It earns its slot mostly for one specific group: people on statins. If that's not you, you can take it or leave it.

Mechanism

Coenzyme Q10 is a cofactor in mitochondrial electron transport — it helps your cells' power plants run — with a secondary effect on blood vessels: it appears to improve endothelial function by easing oxidative stress on nitric oxide signaling. The BP literature is genuinely mixed, though it tilts positive. The effects are smaller than the breathless 2000s-era headlines implied, but they hold up across the better-designed studies. And it's one of the more defensible choices for anyone on a statin, since statins deplete the body's own (endogenous, i.e. self-produced) CoQ10.

Dose and timing

100–200 mg ubiquinol per day with a meal that contains fat. Ubiquinol is the reduced form and absorbs substantially better than ubiquinone, the oxidized form — a gap that widens after about age 50 (this is bioavailability: how much of what you swallow your body can actually use). Morning or midday is fine; a few people report a mild, stimulant-adjacent alertness from it.

Brand we'd buy

Pure Encapsulations Ubiquinol-QH — 100 mg per softgel, Kaneka-sourced ubiquinol (the only ubiquinol form with substantial human trial data behind it), third-party-tested, about $48 for 60 softgels. Qunol Ultra is the mass-market alternative — also Kaneka-sourced, cheaper per mg, slightly more filler in the softgel.

Study

Here's where honesty matters. Rosenfeldt et al. 2007 (J Hum Hypertens, 21:297–306), a meta-analysis of 12 trials, reported a systolic reduction of 11 mmHg and diastolic of 7 mmHg. That's the number you see quoted everywhere — and it's overstated relative to the better-controlled work that followed. The Ho et al. 2016 Cochrane review (CD007435) reanalyzed the evidence and found no significant effect. So the honest framing is a band: modest at worst, meaningful at best, with the strongest case reserved for adults on statins or with measurable mitochondrial-stress markers.

Skip conditions

On warfarin — CoQ10 can lower INR because its structure mimics vitamin K. And it's perfectly reasonable to skip if your BP is already well-controlled and the budget is tight; this is the item with the weakest evidence base in the stack, and we'd rather you spend the money on items 2 and 3.


5. EPA/DHA omega-3 (daily, foundational)

EPA/DHA

IN
Brand
Nordic Naturals ProOmega 2000 — 1,125 mg EPA + 875 mg DHA per two softgels, IFOS-certified for purity and oxidation, third-party-tested. ~$45 / 60 softgels. Carlson Elite EPA Gems is the alternative if you prefer higher EPA-to-DHA ratio.
Dose
2,000–3,000 mg combined EPA+DHA per day, with a fat-containing meal. Read the label carefully — many fish oil products list "1,000 mg fish oil per softgel" but only 300 mg of that is actual EPA+DHA. You want the EPA+DHA number, not the total oil number.
Peel back the label

Mechanism

Long-chain omega-3 fatty acids (EPA + DHA from marine sources) produce modest reductions in BP, more reliably at higher doses (>2 g/day combined EPA+DHA). The mechanism involves endothelial function, reduced inflammation, and improved arterial compliance. Effect is larger in hypertensive subjects and in those with low baseline omega-3 status.

Evidence

Miller et al. 2014 (*Am J Hypertens*, 27:885–896) meta-analysis of 70 RCTs, N=4,484. Doses ≥2 g/day produced systolic reduction of 4.51 mmHg / diastolic 3.05 mmHg in hypertensive subjects. AbuMweis et al. 2018 confirms the dose-response shape. Sub-therapeutic doses (under 1 g/day combined) do not produce the BP effect — this is the most common reason people conclude "fish oil doesn't work."

Skip when

If you are on anticoagulant therapy (warfarin, apixaban, rivaroxaban, dabigatran) — additive bleeding risk, though the absolute risk at these doses is small. Ask your prescriber. Also skip if you have a confirmed fish or shellfish allergy; algae-derived DHA is a partial substitute but EPA content is lower.

supports Stack-kit

The trap with fish oil isn't whether it works — it's the dose, which almost everyone gets wrong by reading the wrong number on the label.

Mechanism

Long-chain omega-3 fatty acids — EPA and DHA from marine sources — produce modest BP reductions, and more reliably so above 2 g/day combined. The mechanism is a mix: better endothelial function, less inflammation, more pliable arteries. As with most of this stack, the effect runs larger in hypertensive subjects and in people who started with low omega-3 levels to begin with.

Dose and timing

2,000–3,000 mg combined EPA+DHA per day, with a fat-containing meal. Now the part that trips everyone: read the label carefully. A bottle that brags "1,000 mg fish oil per softgel" may give you only 300 mg of actual EPA+DHA. The total-oil number is marketing; the EPA+DHA number is the dose. Add up the EPA+DHA, ignore the rest.

Brand we'd buy

Nordic Naturals ProOmega 2000 — 1,125 mg EPA + 875 mg DHA per two softgels, IFOS-certified for purity and oxidation, third-party-tested, about $45 for 60 softgels. Carlson Elite EPA Gems is the alternative if you want a higher EPA-to-DHA ratio.

Study

Miller et al. 2014 (Am J Hypertens, 27:885–896) pooled 70 RCTs, N=4,484. At doses ≥2 g/day, systolic fell 4.51 mmHg and diastolic 3.05 mmHg in hypertensive subjects, and AbuMweis et al. 2018 confirms the dose-response shape. Below 1 g/day combined, the BP effect just isn't there — which is the single most common reason people decide "fish oil doesn't work." They were never on the dose that does.

Skip conditions

On anticoagulant therapy (warfarin, apixaban, rivaroxaban, dabigatran) — there's additive bleeding risk, though the absolute risk at these doses is small. Ask your prescriber anyway. And skip it outright with a confirmed fish or shellfish allergy; algae-derived DHA is a partial workaround, but its EPA content runs lower.


What to cut and why

Four items the evidence does not support — and the reasoning, because "trust us" is not an argument.

L-arginine monotherapy

The nitric-oxide story behind it is real. The supplement isn't the way to reach it. Oral L-arginine raises plasma arginine poorly and the BP effects come out inconsistent. Dietary nitrate (item 2) is the cleaner, better-evidenced route to the exact same downstream endpoint. L-arginine held the default-recommendation slot for two decades; the evidence has since moved, and so should you.

"Heart health" multi-blends

The failure mode is structural, not occasional: cram 8–15 ingredients into one capsule, each at a sub-therapeutic dose. The label reads like a feast; the doses couldn't move a needle. Picture a blend with magnesium at 50 mg, CoQ10 at 30 mg, and "proprietary herbal blend 200 mg" — every active ingredient sits below its trial-grade dose. Buy the individual items at doses that actually do something.

High-dose calcium supplementation

Calcium has been marketed into the cardiovascular conversation for decades, but for BP control specifically it's largely beside the point — and the broader cardiovascular-risk picture is murky. Bolland et al. 2010 (BMJ) raised concerns about vascular calcification at high supplemental intakes, and those concerns were never fully put to rest. If your dietary calcium is adequate, extra supplementation has no place in this stack.

Sodium-loading endurance electrolyte products

These exist for a real purpose — endurance athletes bleeding sodium through sweat over multi-hour efforts. Your situation is the mirror image: an adult whose BP improves when sodium goes down. Marketing has smeared the two categories together. Check the sodium-per-serving and steer around anything that would push your daily intake up.


Frequently asked questions

How fast does this stack work?

On different clocks. Dietary nitrate (item 2) shows measurable BP reductions within hours of the first dose and reaches steady-state in about three days. Magnesium, potassium, and CoQ10 take 4–8 weeks to show their effect. Omega-3 is the slow one — 8–12 weeks to full effect at therapeutic doses. Measure at home with a validated cuff at the same times each morning and evening, and never judge the stack on a single reading; pressure bounces around on its own.

Can this replace my blood pressure medication?

No. Even stacked optimally, the combined effect here is smaller than first-line antihypertensive therapy for most adults with established hypertension. Don't stop anything you've been prescribed. Over time the stack may earn you a conversation with your prescriber about adjusting a dose — but that's their conversation to lead, off your measured readings, not a decision to make from the supplement cabinet.

Why no garlic, hibiscus, or olive leaf extract?

All three have some literature behind them, so this is a judgment call, not a dismissal. Garlic — aged Kyolic specifically — shows ~5 mmHg systolic effects in some trials, but the results are inconsistent and it carries real interaction concerns with anticoagulants. Hibiscus tea has trial support, yet the supplement form is poorly standardized. Olive leaf extract has the thinnest evidence of the three. The five items above simply deliver better-replicated effect sizes per dollar and per interaction risk. Treat these three as reasonable additions later, not as foundations.

What about a DASH diet — does the supplement stack replace it?

It doesn't, and it's not close. The DASH dietary pattern, 150+ minutes/week of zone-2 cardio, sodium reduction, weight management where it applies, and decent sleep architecture produce the larger BP effects by a wide margin. Leave the rest of your life unchanged and the stack alone delivers a small fraction of what those fundamentals do. Think of the stack as a layer on top of that foundation — never a swap for it.

How do I monitor for interactions?

Three concrete steps. First, write down every medication and supplement you take and put the list in front of your prescriber before you start. Second, if you're on an ACE inhibitor, ARB, or potassium-sparing diuretic, request a basic metabolic panel at baseline and again 4–6 weeks after starting potassium. Third, if you're on warfarin, request INR monitoring two weeks after starting CoQ10 or omega-3. The interactions are manageable — the monitoring is the management.

Is the order I take them important?

Less than you'd think, with a few worthwhile placements. Dietary nitrate goes in the morning, since the daytime ambulatory effect is what the studies actually measured. Magnesium goes with the evening meal, where some people also find it mildly calming. CoQ10 and omega-3 ride along with whichever meal carries the most fat. Potassium-as-salt-substitute spreads across meals on its own. Past that, consistency beats sequencing every time.


Stack builder

Build your stack

Tap to add any of these to your stack — or add the whole protocol at once, and skip anything you already own. Everything you add saves on your device; shop your stack whenever you're ready. Stack-kit stays the guide; the store handles checkout, shipping, and any subscription.

Saved on your device Merchant checkout Editorial updates
Shop your stack →
Magnesium glycinate Amazonsupports Stack-kit
Dietary nitrate Amazonsupports Stack-kit
Potassium Amazonsupports Stack-kit
CoQ10 Amazonsupports Stack-kit
EPA/DHA Amazonsupports Stack-kit

Adding is free and stays on your device. When you shop your stack we earn a small commission — same price for you, and it keeps the protocol free. We don't sell or ship supplements ourselves; the store handles checkout and shipping.

Affiliate disclosure

When you buy any of the recommended products through our links, Stack-kit earns an affiliate commission — at no extra cost to you, and with no change to which products we recommend. The five brands above were chosen on third-party testing, dose-per-serving honesty, and trial-grade ingredient sourcing. Not on commission rate. We hold no equity in any brand listed.

Every study cited above is real, retrievable, and named with its N and effect size. Click through to PubMed, and if a number we printed doesn't match the paper, tell us — we'll publish the correction in the changelog at the bottom of this page within 7 days.

This protocol does not replace prescribed therapy and is not medical advice. It's a research-grounded supplement framework for adults managing blood pressure alongside their prescriber. Bring it to that conversation.

How this stays free. When you buy through our links we earn a small commission — and you pay the same price you'd pay going direct to the brand. That's the whole model: no paywall, no house brand to push. We point you to what we'd actually buy, and if a brand's testing slips we change the call and email everyone who bought it. If a protocol earned its place in your stack, buying through us is how you keep it free for the next person. The full money story →
Goals